• Explore /
  • Poster
  • / A phase II study of perioperative intraperitoneal paclitaxel plus S-1/paclitaxel for curatively resectable gastric cancer with serosal invasion: The GAPS study.

A phase II study of perioperative intraperitoneal paclitaxel plus S-1/paclitaxel for curatively resectable gastric cancer with serosal invasion: The GAPS study.

Abstract Poster

Authors

null

Seiji Ito

Aichi Cancer Center Hospital, Aichi, Japan

Seiji Ito , Motohiro Imano , Yoshikazu Uenosono , Takaaki Arigami , Hiroshi Yabusaki , Yasuo Hirono , Shugo Ueda , Tatsuki Matsumura , Ryoji Fukushima , Atsushi Takeno , Kentaro Kishi , Yasutaka Chiba , Sachi Chiba , Haruhiko Imamoto , Yuichi Ito , Atsushi Matsuki , Hironori Ishigami , Hironori Yamaguchi , Joji Kitayama , Hiroshi Furukawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

UMIN000013109

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4033)

DOI

10.1200/JCO.2018.36.15_suppl.4033

Abstract #

4033

Poster Bd #

222

Abstract Disclosures

Similar Posters

First Author: Masaki Aizawa

First Author: John Paul Y.C. Shen

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Safety and efficacy of intraperitoneal paclitaxel plus systemic FOLFOX for gastric cancer with peritoneal metastasis: Phase I results.

Safety and efficacy of intraperitoneal paclitaxel plus systemic FOLFOX for gastric cancer with peritoneal metastasis: Phase I results.

First Author: So Hyun Kang

First Author: Yasuyuki Kawamoto